Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    11870157 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma
Condition: Esophageal Neoplasms
Interventions: Radiation: IMRT simultaneous integrated boost;   Drug: Paclitaxel;   Drug: Nedaplatin;   Procedure: Esophagectomy
2 Completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus
Condition: Esophageal Cancer
Interventions: Drug: chemotherapy;   Drug: cisplatin;   Drug: fluorouracil;   Radiation: low-LET electron therapy;   Radiation: low-LET photon therapy
3 Active, not recruiting Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Neoplasm;   Chemoradiation
Interventions: Drug: Docetaxel;   Drug: Fluorouracil
4 Recruiting Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous Cancer
Conditions: Stage III Esophageal Squamous Cell Carcinoma;   Stage II Esophageal Squamous Cell Carcinoma
Interventions: Other: 2 cycles cisplatin-5-fluorouracil;   Other: 4 cycles cisplatin-5-fluorouracil;   Radiation: Radiotherapy
5 Recruiting Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.
Condition: Esophageal Squamous Cell Carcinoma
Interventions: Radiation: SMART;   Drug: DDP;   Drug: S-1

Study has passed its completion date and status has not been verified in more than two years.